Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases.
Diehl CD, Giordano FA, Grosu AL, Ille S, Kahl KH, Onken J, Rieken S, Sarria GR, Shiban E, Wagner A, Beck J, Brehmer S, Ganslandt O, Hamed M, Meyer B, Münter M, Raabe A, Rohde V, Schaller K, Schilling D, Schneider M, Sperk E, Thomé C, Vajkoczy P, Vatter H, Combs SE. Diehl CD, et al. Among authors: vatter h. Cancers (Basel). 2023 Jul 19;15(14):3670. doi: 10.3390/cancers15143670. Cancers (Basel). 2023. PMID: 37509330 Free PMC article. Review.
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.
Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, Giordano FA, Steinbach JP, Zeiner PS, Kowalski T, Sabel M, Hau P, Krex D, Grauer O, Goldbrunner R, Schnell O, Tabatabai G, Ringel F, Schmidt-Graf F, Brehmer S, Tonn JC, Bullinger L, Vajkoczy P, Glas M, Vatter H, Herrlinger U, Seidel C. Weller J, et al. Among authors: vatter h. J Neurooncol. 2023 Jan;161(1):147-153. doi: 10.1007/s11060-022-04203-4. Epub 2023 Jan 7. J Neurooncol. 2023. PMID: 36609807 Free PMC article. Clinical Trial.
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
Dejonckheere CS, Layer JP, Hamed M, Layer K, Glasmacher A, Friker LL, Potthoff AL, Zeyen T, Scafa D, Koch D, Garbe S, Holz JA, Kugel F, Grimmer M, Schmeel FC, Gielen GH, Forstbauer H, Vatter H, Herrlinger U, Giordano FA, Schneider M, Schmeel LC, Sarria GR. Dejonckheere CS, et al. Among authors: vatter h. J Neurooncol. 2023 Sep;164(3):683-691. doi: 10.1007/s11060-023-04464-7. Epub 2023 Oct 9. J Neurooncol. 2023. PMID: 37812290 Free PMC article.
Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy.
Layer JP, Shiban E, Brehmer S, Diehl CD, de Castro DG, Hamed M, Dejonckheere CS, Cifarelli DT, Friker LL, Herrlinger U, Hölzel M, Vatter H, Schneider M, Combs SE, Schmeel LC, Cifarelli CP, Giordano FA, Sarria GR, Kahl KH. Layer JP, et al. Among authors: vatter h. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1552-1562. doi: 10.1016/j.ijrobp.2024.01.009. Epub 2024 Jan 9. Int J Radiat Oncol Biol Phys. 2024. PMID: 38199383 Free article.
Image Guided Intraoperative Radiation Therapy After Surgical Resection of Brain Metastases: A First In-Human Feasibility Report.
Grimmer M, Sarria GR, Hamed M, Banat M, Kugel F, Lorenzana H, Scafa D, Köksal M, Layer JP, Dejonckheere C, Fiebich M, Schmeel FC, Kowark A, Vatter H, Schmeel LC, Garbe S. Grimmer M, et al. Among authors: vatter h. Adv Radiat Oncol. 2024 Feb 5;9(5):101466. doi: 10.1016/j.adro.2024.101466. eCollection 2024 May. Adv Radiat Oncol. 2024. PMID: 38550377 Free PMC article.
PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial.
Güresir E, Lampmann T, Brandecker S, Czabanka M, Fimmers R, Gempt J, Haas P, Haj A, Jabbarli R, Kalasauskas D, König R, Mielke D, Németh R, Oppong MD, Pala A, Prinz V, Ringel F, Roder C, Rohde V, Schebesch KM, Wagner A, Coch C, Vatter H. Güresir E, et al. Among authors: vatter h. Trials. 2022 Dec 20;23(1):1027. doi: 10.1186/s13063-022-06969-4. Trials. 2022. PMID: 36539817 Free PMC article.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
Weller J, Zeyen T, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger U. Weller J, et al. Among authors: vatter h. J Neurooncol. 2023 Sep;164(3):749-755. doi: 10.1007/s11060-023-04470-9. Epub 2023 Oct 3. J Neurooncol. 2023. PMID: 37787906 Free PMC article.
293 results